248
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Increased radiotoxicity in two cancerous cell lines irradiated by low and high energy photons in the presence of thio-glucose bound gold nanoparticles

, , , &
Pages 407-415 | Received 23 Jul 2015, Accepted 21 Nov 2016, Published online: 12 Jan 2017

References

  • Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P. 2011. Inorganic nanoparticles in cancer therapy. Pharm Res. 28:237–259.
  • Butterworth KT, Coulter J, Jain S, Forker J, Mcmahon S, Schettino G, Prise K, Currell F, Hirst D. 2010. Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology. 21:295101.
  • Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6:662–668.
  • Cho EC, Au l, Zhang Q, Xia Y. 2010. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small. 6:517–522.
  • Chow JC, Leung MK, Fahey S, Chithrani DB, Jaffray DA. 2012. Monte Carlo simulation on low-energy electrons from gold nanoparticle in radiotherapy. J Phys Conf Ser. 341:012012.
  • Essmann F, Engels IH, Totzke G, Schulze-Osthoff K, Jänicke RU. 2004. Apoptosis resistance of MCF-7 breast carcinoma cells to ionizing radiation is independent of p53 and cell cycle control but caused by the lack of caspase-3 and a caffeine-inhibitable event. Cancer Res. 64:7065–7072.
  • Evans H Jr. 1994. CRC handbook of chemistry and physics, 75th ed. Vol. 12. Lide DR, editor. Boston: CRC Press; p. 1.
  • Geng F, Song K, Xing JZ, Yuan C, Yan S, Yang Q, Chen J, Kong B. 2011. Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer. Nanotechnology. 22:285101.
  • Geng F, Xing JZ, Chen J, Yang R, Hao Y, Song K, Kong B. 2014. Pegylated glucose gold nanoparticles for improved in-vivo bio-distribution and enhanced radiotherapy on cervical cancer. J Biomed Nanotechnol. 10:1205–1216.
  • Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. 2008. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol. 60:977–985.
  • Jain S, Hirst D, O’Sullivan J. 2014. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol. 85:101–113.
  • Janicke R, Engels IH, Dunkern T, Kaina B, Schulze-Osthoff K, Porter AG. 2001. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Oncogene. 20:5043–5053.
  • Jiang W, Huang Y, An Y, Kim BY. 2015. Remodeling tumor vasculature to enhance delivery of intermediate-sized nanoparticles. ACS Nano. 9:8689–8696.
  • Kobayashi K, Usami N, Porcel E, Lacombe S, Le Sech C. 2010. Enhancement of radiation effect by heavy elements. Mutat Res. 704:123–131.
  • Kong T, Zeng J, Wang X, Yang X, Yang J, Mcquarrie S, Mcewan A, Roa W, Chen J, Xing JZ. 2008. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small. 4:1537–1543.
  • Lechtman E, Chattopadhyay N, Cai Z, Mashouf S, Reilly R, Pignol J. 2011. Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys Med Biol. 56:4631.
  • Malugin A, Ghandehari H. 2010. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol. 30:212–217.
  • Mesbahi A, Jamali F. 2013. Effect of photon beam energy, gold nanoparticle size and concentration on the dose enhancement in radiation therapy. Bioimpacts. 3:29.
  • Mirkin CA, Niemeyer CM. 2007. Nanobiotechnology II: more concepts and applications. Weinheim: John Wiley & Sons.
  • Mohammadi S, Khoei S, Mahdavi SR. 2012. The combination effect of poly (lactic-co-glycolic acid) coated iron oxide nanoparticles as 5-fluorouracil carrier and X-ray on the level of DNA damages in the DU 145 human prostate carcinoma cell line. J Bionanosci. 6:23–27.
  • Pakravan D, Ghorbani M, Momennezhad M. 2013. Tumor dose enhancement by gold nanoparticles in a 6 MV photon beam: a Monte Carlo study on the size effect of nanoparticles. Nukleonika. 58:275–280.
  • Rahman WN, Bishara N, Ackerly T, He CF, Jackson P, Wong C, Davidson R, Geso M. 2009. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine. 5:136–142.
  • Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175:184–191.
  • Trono JD, Mizuno K, Yusa N, Matsukawa T, Yokoyama K, Uesaka M. 2011. Size, concentration and incubation time dependence of gold nanoparticle uptake into pancreas cancer cells and its future application to X-ray drug delivery system. JRR. 52:103–109.
  • Turner J, Koumenis C, Kute TE, Planalp RP, Brechbiel MW, Beardsley D, Cody B, Brown KD, Torti FM, Torti SV. 2005. Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation. Blood. 106:3191–3199.
  • Van den Heuvel F, Locquet JP, Nuyts S. 2010. Beam energy considerations for gold nanoparticle-enhanced radiation treatment. Phys Med Biol. 55:4509
  • Wang C, Li X, Wang Y, Liu Z, Fu L, Hu L. 2013. Enhancement of radiation effect and increase of apoptosis in lung cancer cells by thio-glucose-bound gold nanoparticles at megavoltage radiation energies. J Nanopart Res. 15:1–12.
  • Wang C, Jiang Y, Li X, Hu L. 2015. Thioglucose-bound gold nanoparticles increase the radiosensitivity of a triple-negative breast cancer cell line (MDA-MB-231). Breast Cancer 22:413–420.
  • Zhang X, Xing JZ, Chen J, Ko L, Amanie J, Gulavita S, Pervez N, Yee D, Moore R, Roa W. 2008. Enhanced radiation sensitivity in prostate cancer by gold nanoparticles. Clin Invest Med. 31:160–167.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.